| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |